Annual Total Long Term Liabilities
$44.76 M
+$28.75 M+179.69%
December 31, 2023
Summary
- As of February 8, 2025, OVID annual total long term liabilities is $44.76 million, with the most recent change of +$28.75 million (+179.69%) on December 31, 2023.
- During the last 3 years, OVID annual total long term liabilities has risen by +$34.52 million (+337.45%).
- OVID annual total long term liabilities is now at all-time high.
Performance
OVID Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$14.73 M
-$337.00 K-2.24%
September 30, 2024
Summary
- As of February 8, 2025, OVID quarterly total long term liabilities is $14.73 million, with the most recent change of -$337.00 thousand (-2.24%) on September 30, 2024.
- Over the past year, OVID quarterly long term liabilities has dropped by -$30.02 million (-67.08%).
- OVID quarterly long term liabilities is now -67.08% below its all-time high of $44.76 million, reached on December 31, 2023.
Performance
OVID Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
OVID Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +179.7% | -67.1% |
| 3 y3 years | +337.4% | -67.1% |
| 5 y5 years | +100.0% | -67.1% |
OVID Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -67.1% | -100.0% |
| 5 y | 5-year | at high | -100.0% | -67.1% | -100.0% |
| alltime | all time | at high | -100.0% | -67.1% | -100.0% |
Ovid Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.73 M(-2.2%) |
| Jun 2024 | - | $15.07 M(-66.1%) |
| Mar 2024 | - | $44.43 M(-0.7%) |
| Dec 2023 | $44.76 M(+179.7%) | $44.76 M(+196.9%) |
| Sep 2023 | - | $15.07 M(-2.1%) |
| Jun 2023 | - | $15.39 M(-2.0%) |
| Mar 2023 | - | $15.70 M(-1.9%) |
| Dec 2022 | $16.00 M(>+9900.0%) | $16.00 M(-1.5%) |
| Sep 2022 | - | $16.25 M(+1.8%) |
| Jun 2022 | - | $15.97 M(+0.6%) |
| Mar 2022 | - | $15.87 M(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $10.23 M | $10.23 M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $10.00 M(+3388.0%) |
| Jun 2020 | - | $286.60 K(0.0%) |
| Mar 2020 | - | $286.60 K(0.0%) |
| Dec 2019 | $286.60 K(>+9900.0%) | $286.60 K(0.0%) |
| Sep 2019 | - | $286.60 K(0.0%) |
| Jun 2019 | - | $286.60 K(-78.6%) |
| Mar 2019 | - | $1.34 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00 |
| Dec 2015 | $0.00 | - |
FAQ
- What is Ovid Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Ovid Therapeutics?
- What is Ovid Therapeutics annual total long term liabilities year-on-year change?
- What is Ovid Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Ovid Therapeutics?
- What is Ovid Therapeutics quarterly long term liabilities year-on-year change?
What is Ovid Therapeutics annual total long term liabilities?
The current annual total long term liabilities of OVID is $44.76 M
What is the all time high annual total long term liabilities for Ovid Therapeutics?
Ovid Therapeutics all-time high annual total long term liabilities is $44.76 M
What is Ovid Therapeutics annual total long term liabilities year-on-year change?
Over the past year, OVID annual total long term liabilities has changed by +$28.75 M (+179.69%)
What is Ovid Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of OVID is $14.73 M
What is the all time high quarterly long term liabilities for Ovid Therapeutics?
Ovid Therapeutics all-time high quarterly total long term liabilities is $44.76 M
What is Ovid Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, OVID quarterly total long term liabilities has changed by -$30.02 M (-67.08%)